期刊文献+

STC1在胃癌组织与外周血液中表达的意义 被引量:3

Significance of STC1 expression in peripheral blood and tissue of gastric carcinoma
下载PDF
导出
摘要 目的:研究外周血液与胃癌组织中斯钙素1(STC1)的表达情况。方法:分别在I-IV型的胃癌74例患者中,应用RT-PCR法检测外周血和肿瘤组织中STC1mRNA表达情况,应用免疫组化法检测肿瘤组织中STC1蛋白表达情况。结果:74例胃癌患者,48例外周血液中STC1mRNA阳性;肿瘤组织STC1mRNA与STC1蛋白全部表达。外周血中STC1mRNA与肿瘤淋巴结转移数、肿瘤大小和病理TNM分期有(r分别为0.637、0.519、0.541,P<0.05、P<0.01、P<0.05)显著正相关。结论:STC1在胃癌的发生发展过程中具有抑制免疫系统功能等重要作用;外周血中STC1mRNA检测可试用作为肿瘤微转移的1个新指标。 AIM: To investigate stanniocalcin 1 (STC1) mRNA expression in the blood and tissue of gastric carcinoma. METHODS : The samples of peripheral blood and tumor tissues were collected from 74 patients with stage Ⅰ-Ⅳ gastric carcinoma. STC1 mRNA was detected by RT-PCR, STC1 protein in tumor tissue was also detected by immuno- histochemical method. RESULTS: The expression of STC1 mRNA in blood was significantly correlated with multiple his- topathological prognostic factors, including primary tumor size, number of positive lymph nodes, and TNM stage. STC1 mRNA was not detected in the blood of volunteers without cancer, but detected in all gastric carcinoma tissue, and STCI protein was expressed in all gastric carcinomas. CONCLUSION: STC1 is proposed as a novel, specific, and clinically useful molecular marker for detecting occult gastric carcinoma cells in blood. STC1 expression may play an important role in the progression of gastric carcinoma.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第5期978-981,共4页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金资助项目(No.5006066)
关键词 斯钙素1 肿瘤转移 胃肿瘤 Stanniocalcin 1 Neoplasms metastasis Stomath neoplasms
  • 相关文献

参考文献10

  • 1Filvaroff EH, GuiUet S, Zlot C, et al. Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice[J]. Endocrinology, 2002, 143(9) :3681 -3690.
  • 2Hasilo CP, McCudden CR, Gillespie JR, et al. Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation [ J ]. Am J Physiol, 2005, 289 (4) : E634 - E642.
  • 3James K, Seitelbach M, McCudden CR, et al. Evidence for stanniocalcin binding activity in mammalian blood and glomerular filtrate [ J ]. Kidney Int, 2005, 67 ( 2 ) : 477 - 482.
  • 4McCudden CR, Majewski A, Chakrabarti S, et al. Co - localization of stanniocalcin - 1 ligand and receptor in human breast carcinomas [ J ]. Mol Cell Endocrinol, 2004, 213(2) :167 - 172.
  • 5Zlot C, Ingle G, Hongo J, et al. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor [J]. J Biol Chem, 2003, 278 ( 48 ) :47654 - 47659.
  • 6Paciga M, James K, GiUespie JR, et al. Evidence for cross-talk between stanniocalcins [ J ]. Can J Physiol Pharmacol, 2005, 83( 11 ) :953 -956.
  • 7Yeung HY, Lai KP, Chan HY, et al. Hypoxia - inducible factor - 1 - mediated activation of stanniocalcin - 1 in human cancer cells [ J ]. Endocrinology, 2005, 146 ( 11 ) : 4951 - 4960.
  • 8Kanellis J, Bick R, Garcia G, et al. Stanniocalcin - 1, an inhibitor of macrophage chemotaxis and chemokinesis [J]. Am J Physiol, 2004, 286(2):F356- F362.
  • 9Fernandez R, Vizoso F, Rodriguez JC, et al. Expression and prognostic significance of pepsinogen C in gastric carcinoma[J]. Ann Surg Oncol, 2000, 7(7) : 508 -514.
  • 10Koziol JA, Zhang JY, Casiano CA, et al. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis [ J ]. Clin Cancer Res, 2003, 9 (14) : 5120 -5126.

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部